Monetary Management Group Inc Mei Pharma, Inc. Transaction History

Monetary Management Group Inc

  • $387 Million
  • Q3 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2021

Feb 14, 2022
SELL
$2.33 - $3.37 $699 - $1,011
-300 Closed
0 $0
Q3 2021

Nov 12, 2021
BUY
$2.52 - $2.99 $756 - $897
300 New
300 $1,000
Q1 2021

May 17, 2021
SELL
$2.73 - $4.5 $819 - $1,350
-300 Closed
0 $0
Q4 2020

Feb 12, 2021
BUY
$2.6 - $3.32 $780 - $996
300 New
300 $1,000

Others Institutions Holding MEIP

# of Institutions
1
Shares Held
2K
Call Options Held
0
Put Options Held
0
View Full List

About MEI Pharma, Inc.

MEIP Quotes by TradingView
  • Ticker MEIP
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 133,261,000
  • Market Cap $333M
  • Description
  • MEI Pharma, Inc., a late-stage pharmaceutical company, focuses on the development and commercialization of various therapies for the treatment of cancer. The company develops Zandelisib, an oral phosphatidylinositol 3-kinase delta inhibitor that is in Phase III clinical trial for the treatment of patients with relapsed/refractory follicular lymp...
More about MEIP
Track This Portfolio

Track Monetary Management Group Inc Portfolio

Follow Monetary Management Group Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Monetary Management Group Inc, based on Form 13F filings with the SEC.

News

Stay updated on Monetary Management Group Inc with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email